26 Aug Bluetree, Nordic among Madison-area tech firms on 2017 Inc. 5000 list
Fourteen Madison-area companies are among the fastest-growing privately owned businesses in the U.S., including two Epic consultant companies. ...
Uncategorized
26 Aug Kiio’s injury-screening technology will get a military workout
When a person enlists in the U.S. military, in addition to going through a standard physical exam, there may also be tests someday for physical strength and range of motion -- if a joint project involving the Department of Defense and a Fitchburg startup proves...
25 Aug Propeller, GSK Expand Collaboration
Propeller Health has extended its 2015 collaboration with GlaxoSmithKline (GSK) to improve management of asthma and COPD, the company announced recently. “We are excited to be working closely with GSK to make the sensor for the ELLIPTA inhaler available in our commercial programs, and for the first...
22 Aug Tele-therapy company DotCom Therapy wins Pressure Chamber pitch contest
DotCom Therapy — a company that provides speech and language therapy to patients via live videoconferencing, and that just moved to Madison this spring — won the Pressure Chamber pitch competition Monday at the Overture Center. It was the second victory in Forward Fest startup contests for...
22 Aug Datica Releases Observations from 7 Healthcare Technology Industry Icons
Datica, the leading cloud platform for digital health applications, today published its seminal Thought Leadership Gallery titled “Rethinking Health Technology” for key stakeholders in healthcare. Industry luminaries like Gregory Ator, MD; Brad Schwartz, MD; Jocelyn DeWitt, PhD; Jacob Behrens, MD, Matt Fenty, Marc Chasin, MD...
08 Aug Cellectar Provides Myeloma Study Update
Cellectar Biosciences’ CLR 131 has achieved an overall survival of greater than 22 months in advanced multiple myeloma patients, the company announced today. “We continue to make meaningful progress on our CLR 131 program and are encouraged by the observed clinical outcomes to date,” Cellectar Biosciences President...
05 Aug Madison Vaccines expands clinical trial for prostate cancer treatment
A Madison drug development company says it is expanding a study of one of its prostate cancer drug prospects as a result of upbeat early results. Madison Vaccines Inc. (MVI) said that after a small, early study of its potential prostate cancer treatment, MVI-816, it has...
05 Aug FluGen brings in more funds from investors
FluGen has added $5.5 million to its coffers to prepare for the next round of studies on RedeeFlu, the nasal spray vaccine the Madison company has developed to protect against influenza. CEO Paul Radspinner says the company is wrapping up its analysis of data from a...
04 Aug Growing wealth of data leading to better outcomes for cancer patients
As researchers search for novel ways to treat and better understand cancer, a growing wealth of data is making these efforts more successful than ever before. “As with any problem, the better we understand it and the more data we get, the more likely that we...
02 Aug FDA announces the launch of the Digital Health Software Pre-certification Pilot Program
In recent years, the Food and Drug Administration (FDA) has taken several steps to streamline and refine the regulatory approval process for health technology, an effort that accelerated substantially following the appointment of Dr. Scott Gottlieb as FDA Commissioner. As a next step in the...